|
Keen to spruce up its activities, Centre is seriously contemplating to constitute a centre of excellence (CoE) specifically dedicated for the Pharmacovigilance Programme of India (PvPI). Through this initiative, the government aims to recognise PvPI as a autonomous body under it, so as to enable focused and robust action plan specifically designed to strengthen it further.
This move comes amid strong representation made by healthcare experts to seriously look into this possibilities as the success and impact of this programme has a huge impact on the health of the patients. Especially, since key health care policies and decision makings are taken by the government based on its observation and analysis.
At present, Indian Pharmacopoeia Commission (IPC) acts as the National Coordination Centre (NCC) for the Pharmacovigilance Programme of India. Incidentally, the need for the same was raised during the completion of five years of IPC as the NCC by stakeholders including IPC.
Dr Kalaiselvan informed that it was mutually agreed upon by all the stakeholders that considering the huge scope of further expanding and spreading the programme, it is imperative to recognise and establish PvPI as a separate entity.
“IPC have been doing a commendable job in strengthening the PvPI programme ever since it’s commitment as NCC. In the last five years we have seen huge development and awareness of the importance of the same through a thorough work approach. We have been able to catapult and help it to grow across the country. However, there is a huge potential yet to be explored, which we strongly believe can be tapped on its full if it’s recognized as a separate department.”
He said that the idea was discussed during the meeting and was positively received by all. However, he did stress that this concept is still being discussed and is at very nascent stage. “We are excited that the government has accepted our proposal although it will take some time for this idea to materialise. We need to deliberate on all the modalities required for such a mammoth task,” he added.
Dr Kalaiselvan informed that in the meantime , IPC will continue to be the NCC, to support and boost the overall performance of PvPI programme to promote safe and efficacious use of medicines.
|